Services
Expertises
Resources
Who we are
Closed

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024

Biopharmaceutical collaboration mission to Germany

Funding available
Varies by project
Deadline
Unspecified
Location
Canada
Who can apply
Small and medium-sized enterprises.
See full eligibility

Overview

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.

At a glance

Funding available

Varies by project

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Access new markets

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
For-profit business

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2025
Periods: 1

Eligibility

Who is eligible?

  • Small and medium-sized enterprises.

Additional information

  • The page is archived and will not be updated.
  • Related program: Canadian International Innovation Program.

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 Program

What is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.

Who is eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program?

To be eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program, you must: Open to small and medium-sized enterprises.

Who can I contact for more information about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

You can contact National Research Council Canada (NRC).

Where is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 available?

The Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program is available across Canada.

Is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 a grant, loan, or tax credit?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is a Partnering and Collaboration

Who are the financial supporters of the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is funded by National Research Council Canada (NRC)